These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma. Shappell SB; Boeglin WE; Olson SJ; Kasper S; Brash AR Am J Pathol; 1999 Jul; 155(1):235-45. PubMed ID: 10393855 [TBL] [Abstract][Full Text] [Related]
5. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848 [TBL] [Abstract][Full Text] [Related]
6. 15-Lipoxygenase-2 expression in benign and neoplastic sebaceous glands and other cutaneous adnexa. Shappell SB; Keeney DS; Zhang J; Page R; Olson SJ; Brash AR J Invest Dermatol; 2001 Jul; 117(1):36-43. PubMed ID: 11442747 [TBL] [Abstract][Full Text] [Related]
7. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer. Li MY; Yuan HL; Ko FW; Wu B; Long X; Du J; Wu J; Ng CS; Wan IY; Mok TS; Hui DS; Underwood MJ; Chen GG Cancer; 2015 Sep; 121 Suppl 17():3130-45. PubMed ID: 26331820 [TBL] [Abstract][Full Text] [Related]
8. Reduced expression of 15-lipoxygenase 2 in human head and neck carcinomas. Wang D; Chen S; Feng Y; Yang Q; Campbell BH; Tang X; Campbell WB Tumour Biol; 2006; 27(5):261-73. PubMed ID: 16874012 [TBL] [Abstract][Full Text] [Related]
9. 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer. Yuan H; Li MY; Ma LT; Hsin MK; Mok TS; Underwood MJ; Chen GG Thorax; 2010 Apr; 65(4):321-6. PubMed ID: 20388757 [TBL] [Abstract][Full Text] [Related]
10. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma. Subbarayan V; Krieg P; Hsi LC; Kim J; Yang P; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG Oncogene; 2006 Sep; 25(44):6015-25. PubMed ID: 16682954 [TBL] [Abstract][Full Text] [Related]
11. Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in peroxisome proliferator-activated receptor gamma. Hsi LC; Wilson LC; Eling TE J Biol Chem; 2002 Oct; 277(43):40549-56. PubMed ID: 12189136 [TBL] [Abstract][Full Text] [Related]
12. Activation of PPARγ by 12/15-lipoxygenase during cerebral ischemia-reperfusion injury. Han J; Sun L; Xu Y; Liang H; Cheng Y Int J Mol Med; 2015 Jan; 35(1):195-201. PubMed ID: 25395029 [TBL] [Abstract][Full Text] [Related]
13. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612 [TBL] [Abstract][Full Text] [Related]
14. Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion. Moussalli MJ; Wu Y; Zuo X; Yang XL; Wistuba II; Raso MG; Morris JS; Bowser JL; Minna JD; Lotan R; Shureiqi I Cancer Prev Res (Phila); 2011 Dec; 4(12):1961-72. PubMed ID: 21881028 [TBL] [Abstract][Full Text] [Related]
15. Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia. Subbarayan V; Xu XC; Kim J; Yang P; Hoque A; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG Neoplasia; 2005 Mar; 7(3):280-93. PubMed ID: 15799828 [TBL] [Abstract][Full Text] [Related]
16. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer. Liu J; Ping W; Zu Y; Sun W Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249 [TBL] [Abstract][Full Text] [Related]
17. A word of caution regarding napsin A expression in squamous cell carcinomas of the lung. Ordóñez NG Am J Surg Pathol; 2012 Mar; 36(3):396-401. PubMed ID: 22198009 [TBL] [Abstract][Full Text] [Related]
18. 15-Lipoxygenase-2/15(S)-hydroxyeicosatetraenoic acid regulates cell proliferation and metastasis via the STAT3 pathway in lung adenocarcinoma. Yang L; Ma C; Zhang L; Zhang M; Li F; Zhang C; Yu X; Wang X; He S; Zhu D; Song Y Prostaglandins Other Lipid Mediat; 2018 Sep; 138():31-40. PubMed ID: 30110652 [TBL] [Abstract][Full Text] [Related]
19. Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma. Shappell SB; Manning S; Boeglin WE; Guan YF; Roberts RL; Davis L; Olson SJ; Jack GS; Coffey CS; Wheeler TM; Breyer MD; Brash AR Neoplasia; 2001; 3(4):287-303. PubMed ID: 11571629 [TBL] [Abstract][Full Text] [Related]
20. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins. Myong NH J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]